<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Surgery and Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Surgery and Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Хирургия и онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="electronic">2949-5857</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28</article-id><article-id pub-id-type="doi">10.17650/2220-3478-2012-0-1-7-10</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>IN FOCUS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>В ЦЕНТРЕ ВНИМАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">MULTIDISCIPLINARY TREATMENT OF RECTAL CANCER: THE ASSESSMENT OF CLINICAL AND PATHOLOGIC RESPONSE FOR LOCALLY ADVANCED RECTAL CANCER TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY</article-title><trans-title-group xml:lang="ru"><trans-title>МУЛЬТИДИСЦИПЛИНАРНЫЙ ПОДХОД К ЛЕЧЕНИЮ БОЛЬНЫХ РАКОМ ПРЯМОЙ КИШКИ: ОЦЕНКА КЛИНИЧЕСКОГО И ПАТОЛОГИЧЕСКОГО ОТВЕТА У БОЛЬНЫХ, ПОЛУЧАВШИХ ПРЕДОПЕРАЦИОННУЮ ХИМИОЛУЧЕВУЮ ТЕРАПИЮ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pravosudov</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Правосудов</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>pravosudov@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aliyev</surname><given-names>I. I.</given-names></name><name xml:lang="ru"><surname>Алиев</surname><given-names>И. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shulepov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Шулепов</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Krzhivitsky</surname><given-names>P. I.</given-names></name><name xml:lang="ru"><surname>Крживицкий</surname><given-names>П. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Petrov Research Institute of Oncology, Ministry of Health and Social Development of Russia, Saint Petersburg</institution></aff><aff><institution xml:lang="ru">ФГБУ НИИ онкологии им. Н.Н. Петрова Минздравсоцразвития России, Санкт-Петербург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-02-26" publication-format="electronic"><day>26</day><month>02</month><year>2012</year></pub-date><volume>1</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>7</fpage><lpage>10</lpage><history><date date-type="received" iso-8601-date="2015-02-26"><day>26</day><month>02</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-02-26"><day>26</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, ABV-press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, АБВ-пресс</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">ABV-press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://onco-surgery.info/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://onco-surgery.info/jour/article/view/28">https://onco-surgery.info/jour/article/view/28</self-uri><abstract xml:lang="en"><p>Preoperative staging by digital examination, endorectal ultrasound and magnetic resonance imaging (MRI) allows an assessment of the risk of local recurrence after surgery alone. The successful management of rectal cancer requires a multidisciplinary approach, with treatment decisions based on precise patient evaluations. Chemoradiotherapy (CRT) is associated with reduction of tumor size and downstaging.The aim of this study is to assess how often complete clinical response is achieved after eoadjuvant CRT and its concordance with pathologic complete response.Results. Patients with biopsy-proven, locally advanced rectal cancer (T3, T4) were treated by CRT followed by radical surgery. Tumors were re-assessed after 8 weeks from CRT completion using MRI and endoscopic examination. The results of examination were comparedwith the final histopathologic status.Conclusions. Neoadjuvant CRT leads to significant tumor regression and in some patients there is complete disappearance of neoplasm. MRI combining with colonoscopic findings is a useful tool to evaluate these features.</p></abstract><trans-abstract xml:lang="ru"><p>Предоперационное стадирование с использованием инструментальных методов диагностики: эндоректальной ультрасонографии и магнитно-резонансной томографии (МРТ) позволяет оценить риск развития местного рецидива после хирургического лечения рака прямой кишки (РПК).Успешное лечение РПК требует мультидисциплинарного подхода, использования химиолучевой терапии (ХЛТ).Цель исследования: оценить, как часто достигается полный клинический ответ после неоадъювантной ХЛТ и каково его соотношение с полным патологическим регрессом.Результаты. Пациенты с местно-распространенным РПК (T3, T4), морфологически подтвержденным, подвергались ХЛТ с последующей радикальной операцией. Оценка эффекта производилась через 8 нед после завершения ХЛТ с помощью МРТ и эндоскопического исследования. Результаты сравнивались с окончательным гистологическим заключением.Выводы. Неоадъювантная ХЛТ приводит к существенному регрессу опухоли, а у некоторых пациентов к ее полному исчезновению. МРТ вместе с фиброколоноскопией позволяют оценить эффект лечения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>rectal cancer</kwd><kwd>magnetic resonance imaging</kwd><kwd>chemoradiotherapy</kwd><kwd>complete clinical response</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак прямой кишки</kwd><kwd>магнитно-резонансная томография</kwd><kwd>химиолучевая терапия</kwd><kwd>полный клинический ответ</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Злокачественные новообразования в России в 2004 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского. М.: Антиф, 2005. 258 с.</mixed-citation><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2004 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского. М.: Антиф, 2005. 258 с.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Sauer R., Becker H., Hohenberger W. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–40.</mixed-citation><mixed-citation xml:lang="ru">Sauer R., Becker H., Hohenberger W. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–40.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Vauthey J.N., Marsh R.W., Zlotecki R.A. et al. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg 1999;229(5):745–54.</mixed-citation><mixed-citation xml:lang="ru">Vauthey J.N., Marsh R.W., Zlotecki R.A. et al. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg 1999;229(5):745–54.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Kapiteijn E., Marijnen C.A., Nastegaal I.D. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 200;345:638–46.</mixed-citation><mixed-citation xml:lang="ru">Kapiteijn E., Marijnen C.A., Nastegaal I.D. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 200;345:638–46.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Perez R.O, Habr-Gama A., Proscurshim I. et al. Local excision for ypT2 rectal cancer — much ado about something. J Gastrointest Surg 2007;11:1431–40.</mixed-citation><mixed-citation xml:lang="ru">Perez R.O, Habr-Gama A., Proscurshim I. et al. Local excision for ypT2 rectal cancer — much ado about something. J Gastrointest Surg 2007;11:1431–40.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Chan A.K., Wong A., Jenken D. et al. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:665–77.</mixed-citation><mixed-citation xml:lang="ru">Chan A.K., Wong A., Jenken D. et al. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:665–77.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Kim D.W., Kim D.Y., Kim T.H. et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 2006;106:1694–700.</mixed-citation><mixed-citation xml:lang="ru">Kim D.W., Kim D.Y., Kim T.H. et al. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 2006;106:1694–700.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Stipa F., Chessin D.B., Shia J. et al. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006;13:1047–53.</mixed-citation><mixed-citation xml:lang="ru">Stipa F., Chessin D.B., Shia J. et al. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006;13:1047–53.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Quirke P., Dixon M.F. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3(2):127–31.</mixed-citation><mixed-citation xml:lang="ru">Quirke P., Dixon M.F. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 1988;3(2):127–31.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Capirci C., Valentini V., Cionini L. et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72(1):99–107.</mixed-citation><mixed-citation xml:lang="ru">Capirci C., Valentini V., Cionini L. et al. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72(1):99–107.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Rödel C., Martus P., Papadoupolos T. et al. Prognostic significance of tumor regression after preoperative radiotherapy for rectal cancer. J Clin Oncol 2005;23(34):8688–96.</mixed-citation><mixed-citation xml:lang="ru">Rödel C., Martus P., Papadoupolos T. et al. Prognostic significance of tumor regression after preoperative radiotherapy for rectal cancer. J Clin Oncol 2005;23(34):8688–96.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Chen C.C., Lee R.C., Lin J.K. et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005;48(4):722–8.</mixed-citation><mixed-citation xml:lang="ru">Chen C.C., Lee R.C., Lin J.K. et al. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005;48(4):722–8.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. MERCURY study group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333(7572):779–84.</mixed-citation><mixed-citation xml:lang="ru">MERCURY study group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333(7572):779–84.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Smith N.J., Barbahano Y., Norman A.R. et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2007;95(2):229–36.</mixed-citation><mixed-citation xml:lang="ru">Smith N.J., Barbahano Y., Norman A.R. et al. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2007;95(2):229–36.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Eisenhauer E.A. et al. New response evalution criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228–47.</mixed-citation><mixed-citation xml:lang="ru">Eisenhauer E.A. et al. New response evalution criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228–47.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Blomqvist L., Machado M., Rubio C. et al. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 2000;10(4):653–60.</mixed-citation><mixed-citation xml:lang="ru">Blomqvist L., Machado M., Rubio C. et al. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 2000;10(4):653–60.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Fuchsjäger M.H., Maier A.G., Schima W. et al. Comparison of transrectal sonography and double — contrast MR imaging when staging rectal cancer. Am J Roentgenol 2003;181(2):421–7.</mixed-citation><mixed-citation xml:lang="ru">Fuchsjäger M.H., Maier A.G., Schima W. et al. Comparison of transrectal sonography and double — contrast MR imaging when staging rectal cancer. Am J Roentgenol 2003;181(2):421–7.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Theodoropoulos G., Wise W.E., Padmanabhan A. et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer results in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:895–903.</mixed-citation><mixed-citation xml:lang="ru">Theodoropoulos G., Wise W.E., Padmanabhan A. et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer results in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:895–903.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Garcia-Aguilar J., Hernandez de Anda E., Sirivongs P. et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298–304.</mixed-citation><mixed-citation xml:lang="ru">Garcia-Aguilar J., Hernandez de Anda E., Sirivongs P. et al. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298–304.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Crane C.H., Skibber J.M., Birnbaum E.H. et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumour response, leading to increased sphincter preservation in locally advanced low rectal cancer. Int J Radiat Oncol Biol Phys 2003;57:84–9.</mixed-citation><mixed-citation xml:lang="ru">Crane C.H., Skibber J.M., Birnbaum E.H. et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumour response, leading to increased sphincter preservation in locally advanced low rectal cancer. Int J Radiat Oncol Biol Phys 2003;57:84–9.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Guillem J.G., Chessin D.B., Shia J. et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate endpoint. J Clin Oncol 2005;23:3475–9.</mixed-citation><mixed-citation xml:lang="ru">Guillem J.G., Chessin D.B., Shia J. et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate endpoint. J Clin Oncol 2005;23:3475–9.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Habr-Gama A., Perez R.O., Nadalin W. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: longterm results. Ann Surg 2004;240:711–7.</mixed-citation><mixed-citation xml:lang="ru">Habr-Gama A., Perez R.O., Nadalin W. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: longterm results. Ann Surg 2004;240:711–7.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Hoffmann K.T., Rau B., Wust P. et al. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Oncol 2002;178(7):386–92.</mixed-citation><mixed-citation xml:lang="ru">Hoffmann K.T., Rau B., Wust P. et al. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Oncol 2002;178(7):386–92.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Maier A.G., Barton P.P., Neuhold N.R. et al. Peritumoral tissue reaction at transrectal US as a possible cause of overstaging in rectal cancer: histopathologic correlation. Radiology 1997;203(3):785–9.</mixed-citation><mixed-citation xml:lang="ru">Maier A.G., Barton P.P., Neuhold N.R. et al. Peritumoral tissue reaction at transrectal US as a possible cause of overstaging in rectal cancer: histopathologic correlation. Radiology 1997;203(3):785–9.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
